Claudia Allemani

Claudia Allemani is Professor of Global Public Health at the London School of Hygiene & Tropical Medicine (LSHTM), where she leads the Cancer Survival Group within the Department of Non-Communicable Disease Epidemiology in the Faculty of Epidemiology and Population Health. With over 20 years of experience in cancer epidemiology, she serves as co-Principal Investigator for the global CONCORD cancer surveillance program and Principal Investigator for the ERC-funded VENUSCANCER project studying worldwide inequalities in cancer survival.

Her educational background spans applied mathematics to public health, with degrees including an MSc in Mathematics from the University of Turin (1996), MSc in Statistical and Informatic Methods from the University of Milan (1998), a PhD equivalent in Medical Statistics (2001), and a PhD in Public Health and Education (2006), all from Italian institutions.

Professor Allemani's research focuses on international comparisons of cancer survival trends, high-resolution studies on patterns of care, and estimation of avoidable premature deaths with direct impact on cancer policy. Her work encompasses multiple cancer types across more than 70 countries, examining how healthcare systems, socioeconomic factors, and policy interventions affect cancer outcomes globally. She has pioneered methodologies for population-based cancer survival analysis that have become standard in the field.

Her extensive publication record demonstrates consistent focus on global cancer surveillance, with particular attention to breast, cervical, and ovarian cancers, as well as pediatric malignancies. The research shows clear evolution from European-focused studies (EUROCARE) to truly global population-based analyses (CONCORD), reflecting growing recognition of cancer as a worldwide health challenge requiring international comparative approaches.

• Fellow of the Higher Education Academy (2012)
• Honorary Member of the UK Faculty of Public Health (2014)
• UK Faculty of Public Health's inaugural Global Public Health Award (2016)
• European Research Council Consolidator grant recipient (2017)
• Member of The Lancet Oncology International Advisory Board (2021-2024)
• Co-Chair of the CONCORD-Lancet Global Commission on Cancer

Professor Allemani actively supervises PhD students and teaches across multiple MSc programs at LSHTM, particularly in epidemiology and medical statistics. Her grant portfolio includes major funding from the European Research Council, Cancer Research UK, CDC, WHO, and other international bodies supporting the CONCORD program's expansion to include 22 adult cancers and all childhood cancers diagnosed from 2000-2019 across 70+ countries.

She leads a dedicated team of five researchers in the Cancer Survival Group, collaborating with major international health organizations including the Organisation for Economic Co-operation and Development, US Centers for Disease Control and Prevention, Institute for Health Metrics and Evaluation, WHO, International Atomic Energy Agency, and numerous national cancer institutes to translate survival data into actionable cancer control policies worldwide.